TIGIT and acute myeloid leukemia: Notably, we found a high ratio of TIGIT/DNAM-1 expression in Foxp3+ γδ T cells in de novo AML patients (median: 1.00) compared to HIs (median: 0.69) (P = 0.040) (Figure 2(e)).